As diabetes care continues to be a major focus, new treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a remarkable advancement in GLP-1 receptor agonist medications. While all https://bookmarkshut.com/story23822036/retatrutid-vs-tirzepatide-vs-semaglutide-a-comparative-analysis